GlassScriptPhysician profile
Krista Hobbs
NPI 1235656208
$3,006.07
in general payments reported to CMS, 2019-2025
47 companies · $592 in 2025
The $592 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $659 · 2022: $264 · 2023: $657 · 2024: $834 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,692 · Education: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,692.47 |
| Education | $390.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $471.43 | 2022-2025 | Optune, Optune Gio, Optune Lua (Novottf-200t) |
| Janssen Biotech, INC. | $300.72 | 2021-2025 | Imbruvica, Talvey, Erleada |
| Incyte Corporation | $150.58 | 2021-2025 | Jakafi, Monjuvi |
| Merck Sharp & Dohme LLC | $143.76 | 2023-2024 | Keytruda, Lynparza, Welireg |
| Amgen INC. | $121.86 | 2021 | |
| Seagen INC. | $114.05 | 2021-2023 | |
| Pfizer INC. | $110.14 | 2021-2024 | |
| Ipsen Biopharmaceuticals, INC | $108.41 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $99.48 | 2023-2024 | Imfinzi |
| Pharmacyclics LLC, An Abbvie Company | $92.45 | 2021-2023 | Imbruvica, Epkinly |
| Aveo Pharmaceuticals, INC. | $91.40 | 2025 | |
| Rigel Pharmaceuticals, INC. | $88.89 | 2021-2024 | Rezlidhia, Tavalisse |
| Daiichi Sankyo INC. | $58.96 | 2021-2025 | Enhertu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.77 | 2021-2024 | Gilotrif |
| Lilly USA, LLC | $57.12 | 2021-2025 | Verzenio, Jaypirca |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krista Hobbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.